Last update Jan. 3, 2022
It is an anthelmintic, derived from benzimidazole, with activity against most nematode worms. Withdrawn from the market in many countries due to less toxic, safer and more effective alternatives. Oral administration twice a day for one or two days.
Since the last update we have not found any published data on its excretion in breast milk.
The paucity of known pharmacokinetic data does not allow prediction of its excretion in human milk.
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable, especially during the neonatal period and in the event of prematurity.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM